Sara López-Tarruella

15PUBLICATIONS
80CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 24, 2026
Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM).

Sara López-Tarruella, Ángel Guerrero-Zotano, Silvia Antolín

|Aug 21, 2025
Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials.

Andrea Blasco, Sara López-Tarruella, Ander Urruticoechea

|Apr 04, 2025
Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies.

Sara Lopez-Tarruella, Marina Pollán, Eva Carrasco

|Feb 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.

Rita A Mukhtar, Soumya Gottipati, Christina Yau

|Apr 01, 2024
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.

N Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez

|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.

Miguel Martín, Rachel Yoder, Roberto Salgado

Pageof 3